Markets:

Overview

News

Currencies

International

Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

3.920 -0.060 (-1.51%)

Streaming Delayed Price Updated: 3:43 PM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

10 Fintech Stocks To Own Until 2032 and Beyond ↗

February 08, 2022

While falling out of favor for now, in the long-term the 'digitalization of money' trend could send these 10 fintech stocks higher.

Via InvestorPlace

SoFi Gets Bank License, But That’s Not Necessarily a Good Thing ↗

February 04, 2022

A bank chart isn't the solution to SOFI stock's issues

Via InvestorPlace

CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7 ↗

February 02, 2022

Clover Health Investments (CLOV) stock is on the move Wednesday following a new price prediction from Cowen analyst Gary Taylor.

Via InvestorPlace

Expert Ratings For Clover Health Investments ↗

February 02, 2022

Within the last quarter, Clover Health Investments (NASDAQ:CLOV) has observed the following analyst ratings:

Via Benzinga

Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Notice: Update in Lawsuit ↗

February 02, 2022

San Diego, CA -- (SBWIRE) -- 02/02/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp....

Via SBWire

Clover Health Stock Remains a High-Risk High-Reward Play ↗

January 24, 2022

Both Clover Health's bear and bull cases are equally compelling, which makes CLOV stock a highly risky bet right now.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022 ↗

February 02, 2022

Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 02, 2022

Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million....

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

February 02, 2022

Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.

Via Benzinga

7 Worst SPACs for Smart Investors to Skip in 2022 ↗

January 26, 2022

SPACs may make a comeback in 2022. But some of them won't ever recover. These 7 SPACs have a challenging future ahead of themselves.

Via InvestorPlace

At Below $3 Clover Health Stock May Be Worth It as a Moonshot ↗

January 24, 2022

It's unclear whether fortunes will turn around for CLOV stock this year, but among meme plays it may have the most comeback potential.

Via InvestorPlace

Membership Growth Is Making Clover Health a More Convincing Investment ↗

January 19, 2022

You can hold CLOV stock in hopes of another Reddit run-up, but there are also positive data points to support a long-term investment.

Via InvestorPlace

Why Chamath Palihapitiya Is Facing Backlash For His Comments On Uyghur Genocide ↗

January 18, 2022

Billionaire venture capitalist Chamath Palihapitiya is under fire for comments he made on a podcast dismissing human rights abuses against the Uyghurs in China. What Happened:...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 ↗

January 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

Via Benzinga

Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision ↗

January 18, 2022

CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players.

Via InvestorPlace

Camber Energy, Clover Health, Globalstar Stocks Continue Lower In Key Trend: Will The Bloodbath End? ↗

January 14, 2022

Camber Energy, Inc (NYSE: CEI), Clover Health Investments Corp (NASDAQ: CLOV) and Globalstar, Inc (NYSE: GSAT) are all trading higher in strong downtrends. A downtrend occurs when...

Via Benzinga

Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet ↗

January 14, 2022

Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud.

Via InvestorPlace

Polestar Looks Like the Right EV Stock At the Wrong Time ↗

January 13, 2022

Polestar has a lot of what I look for in a growth stock. But with valuations likely to correct further, there's no hurry to jump in now.

Via InvestorPlace

RCL Stock Pressured by Hindenburg Short: 7 Things to Know ↗

January 10, 2022

RCL stock is in the red since 2022 kicked off. Now, Hindenburg Research is taking full advantage of the cruise company's weaknesses.

Via InvestorPlace

How Did the Meme Stocks Do Last Year? Here’s How ↗

January 08, 2022

Quick, which ones were over 500% up? And which six were more than 45% down?

Via Talk Markets

CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low ↗

January 07, 2022

Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.

Via InvestorPlace

DeskTop Metal Shares Are Still Off Limits to Buyers ↗

January 07, 2022

Off and on the price chart, there's work to be done in DM stock before bullish investors consider taking a long position.

Via InvestorPlace

The Two Faces of Clover Health ↗

January 06, 2022

The Clover Assistant may be great software, but the company behind it is questionable. CLOV Stock is best to be avoided for now.

Via InvestorPlace

2021: The Year in Charts ↗

January 05, 2022

A look at the charts and themes that tell the story of 2021.

Via Talk Markets

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

The Steep Drop In Clover Health Stock Sets up an Entry Opportunity ↗

December 29, 2021

Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here.

Via InvestorPlace

Clover Health Is Not the $2 Billion Stock to Buy for 2022 ↗

December 24, 2021

Clover Health's market cap dropped 74% in 2021. As we head into 2022, CLOV stock is not the $2 billion market cap you want to buy.

Via InvestorPlace

7 of The Best SPAC Stocks to Put on Your 2022 Watchlist ↗

December 23, 2021

SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending.

Via InvestorPlace

3 Sleeper Stocks to Buy Now Before 2022 Rolls In ↗

December 23, 2021

2021 is almost over and it produced many ideas for stocks to buy on weakness. Here are three that may recapture investor attention next year.

Via InvestorPlace

7 Meme Stocks to Sell Before They Lose Momentum ↗

December 17, 2021

Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear.

Via InvestorPlace

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Delivering useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/pages/Cabling-Installation-and-Maintenance/298118662118

https://www.instagram.com/cim_magazine/

https://www.linkedin.com/company/3962332

http://twitter.com/CABLINGMAG

Affiliated Brands

DATA CENTER FRONTIER

ISE

LIGHTWAVE

DIGITAL INFRASTRUCTURE GROUP

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions